OVERCOMING MULTIPLE MYELOMA DRUG RESISTANCE IN THE ERA OF CANCER “OMICS”

Multiple myeloma (MM) is amongst the most compelling examples of cancer in which research has markedly improved the length and quality of lives of those afflicted. Research efforts have led to 18 newly approved treatments over the last 12 years, including 7 in 2015. However, despite significant impr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Leuk Lymphoma
Autori principali: Guang, Matthew Ho Zhi, McCann, Amanda, Bianchi, Giada, Zhang, Li, Dowling, Paul, Bazou, Despina, O’Gorman, Peter, Anderson, Kenneth C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6152877/
https://ncbi.nlm.nih.gov/pubmed/28610537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2017.1337115
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi